A combined biomarker panel shows improved sensitivity and specificity for detection of ovarian cancer

BACKGROUND: Combined biomarkers can improve the sensitivity and specificity of ovarian cancer (OC) diagnosis and effectively predict patient prognosis. This study explored the diagnostic and prognostic values of serum CCL18 and CXCL1 antigens combined with C1D, FXR1, ZNF573, and TM4SF1 autoantibodie...

Descripción completa

Detalles Bibliográficos
Autores principales: Mao, Lu, Tang, Yong, Deng, Ming‐jing, Huang, Chun‐tao, Lan, Dong, Nong, Wen‐Zheng, Li, Li, Wang, Qi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842139/
https://www.ncbi.nlm.nih.gov/pubmed/34995016
http://dx.doi.org/10.1002/jcla.24232

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842139/
https://www.ncbi.nlm.nih.gov/pubmed/34995016
http://dx.doi.org/10.1002/jcla.24232

Ejemplares similares